Annual Revenue
$509.34 M
-$28.50 M-5.30%
31 December 2023
Summary:
NovoCure Limited annual revenue is currently $509.34 million, with the most recent change of -$28.50 million (-5.30%) on 31 December 2023. During the last 3 years, it has risen by +$14.97 million (+3.03%). NVCR annual revenue is now -5.30% below its all-time high of $537.84 million, reached on 31 December 2022.NVCR Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$155.09 M
+$4.74 M+3.15%
30 September 2024
Summary:
NovoCure Limited quarterly revenue is currently $155.09 million, with the most recent change of +$4.74 million (+3.15%) on 30 September 2024. Over the past year, it has increased by +$27.77 million (+21.81%). NVCR quarterly revenue is now at all-time high.NVCR Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$577.74 M
+$27.77 M+5.05%
30 September 2024
Summary:
NovoCure Limited TTM revenue is currently $577.74 million, with the most recent change of +$27.77 million (+5.05%) on 30 September 2024. Over the past year, it has increased by +$73.75 million (+14.63%). NVCR TTM revenue is now at all-time high.NVCR TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVCR Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.3% | +21.8% | +14.6% |
| 3 y3 years | +3.0% | +16.1% | +5.9% |
| 5 y5 years | +105.3% | +68.5% | +79.6% |
NVCR Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -5.3% | +3.0% | at high | +26.9% | at high | +14.6% |
| 5 y | 5 years | -5.3% | +105.3% | at high | +68.5% | at high | +79.6% |
| alltime | all time | -5.3% | +4816.9% | at high | +3980.4% | at high | >+9999.0% |
NovoCure Limited Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $155.09 M(+3.2%) | $577.74 M(+5.1%) |
| June 2024 | - | $150.36 M(+8.6%) | $549.96 M(+4.6%) |
| Mar 2024 | - | $138.50 M(+3.5%) | $525.66 M(+3.2%) |
| Dec 2023 | $509.34 M(-5.3%) | $133.78 M(+5.1%) | $509.34 M(+1.1%) |
| Sept 2023 | - | $127.32 M(+1.0%) | $503.98 M(-0.7%) |
| June 2023 | - | $126.05 M(+3.2%) | $507.66 M(-2.8%) |
| Mar 2023 | - | $122.18 M(-4.9%) | $522.48 M(-2.9%) |
| Dec 2022 | $537.84 M(+0.5%) | $128.43 M(-2.0%) | $537.84 M(-0.9%) |
| Sept 2022 | - | $131.00 M(-7.0%) | $542.62 M(-0.5%) |
| June 2022 | - | $140.87 M(+2.4%) | $545.23 M(+1.4%) |
| Mar 2022 | - | $137.55 M(+3.3%) | $537.88 M(+0.5%) |
| Dec 2021 | $535.03 M(+8.2%) | $133.21 M(-0.3%) | $535.03 M(-2.0%) |
| Sept 2021 | - | $133.61 M(+0.1%) | $545.77 M(+0.2%) |
| June 2021 | - | $133.52 M(-0.9%) | $544.83 M(+3.3%) |
| Mar 2021 | - | $134.69 M(-6.4%) | $527.23 M(+6.6%) |
| Dec 2020 | $494.37 M(+40.7%) | $143.95 M(+8.5%) | $494.37 M(+9.9%) |
| Sept 2020 | - | $132.66 M(+14.4%) | $449.65 M(+9.9%) |
| June 2020 | - | $115.92 M(+13.8%) | $409.05 M(+7.7%) |
| Mar 2020 | - | $101.83 M(+2.6%) | $379.84 M(+8.1%) |
| Dec 2019 | $351.32 M | $99.23 M(+7.8%) | $351.32 M(+9.2%) |
| Sept 2019 | - | $92.06 M(+6.2%) | $321.76 M(+9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $86.71 M(+18.3%) | $294.45 M(+9.4%) |
| Mar 2019 | - | $73.31 M(+5.2%) | $269.25 M(+8.5%) |
| Dec 2018 | $248.07 M(+40.1%) | $69.67 M(+7.6%) | $248.07 M(+6.9%) |
| Sept 2018 | - | $64.76 M(+5.3%) | $232.06 M(+6.7%) |
| June 2018 | - | $61.51 M(+18.0%) | $217.41 M(+11.9%) |
| Mar 2018 | - | $52.13 M(-2.9%) | $194.27 M(+9.7%) |
| Dec 2017 | $177.03 M(+113.6%) | $53.66 M(+7.1%) | $177.03 M(+15.2%) |
| Sept 2017 | - | $50.11 M(+30.6%) | $153.61 M(+22.7%) |
| June 2017 | - | $38.38 M(+10.0%) | $125.17 M(+19.5%) |
| Mar 2017 | - | $34.88 M(+15.3%) | $104.72 M(+26.3%) |
| Dec 2016 | $82.89 M(+150.5%) | $30.24 M(+39.5%) | $82.89 M(+27.5%) |
| Sept 2016 | - | $21.67 M(+21.0%) | $65.03 M(+24.3%) |
| June 2016 | - | $17.92 M(+37.3%) | $52.31 M(+27.8%) |
| Mar 2016 | - | $13.05 M(+5.4%) | $40.93 M(+23.7%) |
| Dec 2015 | $33.09 M(+113.6%) | $12.38 M(+38.3%) | $33.09 M(+35.0%) |
| Sept 2015 | - | $8.95 M(+36.8%) | $24.50 M(+23.0%) |
| June 2015 | - | $6.54 M(+25.6%) | $19.93 M(+48.9%) |
| Mar 2015 | - | $5.21 M(+37.0%) | $13.38 M(+63.7%) |
| Dec 2014 | $15.49 M(+49.5%) | $3.80 M(-13.1%) | $8.18 M(+86.9%) |
| Sept 2014 | - | $4.37 M | $4.37 M |
| Dec 2013 | $10.36 M | - | - |
FAQ
- What is NovoCure Limited annual revenue?
- What is the all time high annual revenue for NovoCure Limited?
- What is NovoCure Limited annual revenue year-on-year change?
- What is NovoCure Limited quarterly revenue?
- What is the all time high quarterly revenue for NovoCure Limited?
- What is NovoCure Limited quarterly revenue year-on-year change?
- What is NovoCure Limited TTM revenue?
- What is the all time high TTM revenue for NovoCure Limited?
- What is NovoCure Limited TTM revenue year-on-year change?
What is NovoCure Limited annual revenue?
The current annual revenue of NVCR is $509.34 M
What is the all time high annual revenue for NovoCure Limited?
NovoCure Limited all-time high annual revenue is $537.84 M
What is NovoCure Limited annual revenue year-on-year change?
Over the past year, NVCR annual revenue has changed by -$28.50 M (-5.30%)
What is NovoCure Limited quarterly revenue?
The current quarterly revenue of NVCR is $155.09 M
What is the all time high quarterly revenue for NovoCure Limited?
NovoCure Limited all-time high quarterly revenue is $155.09 M
What is NovoCure Limited quarterly revenue year-on-year change?
Over the past year, NVCR quarterly revenue has changed by +$27.77 M (+21.81%)
What is NovoCure Limited TTM revenue?
The current TTM revenue of NVCR is $577.74 M
What is the all time high TTM revenue for NovoCure Limited?
NovoCure Limited all-time high TTM revenue is $577.74 M
What is NovoCure Limited TTM revenue year-on-year change?
Over the past year, NVCR TTM revenue has changed by +$73.75 M (+14.63%)